Re: B cell antibodies

From: Timothy Singleton, M.D. (tsingleton@smtpgw.beaumont.edu)
Date: Fri May 24 2002 - 16:13:30 EST


Cytoplasmic CD79a.

Tim Singleton, MD
Flow Cytometry
Beaumont Hospital
Royal Oak, MI

>>> Paula Fukushima <pif@mail.nih.gov> 05/24/02 09:40AM >>>

Hi List,
    Does anyone have an idea of B cell antibodies to use to follow
disease
in B cell lymphomas
with patients now being given anti-CD22(Epratuzumab) and
anti-CD20(Rituxamab) besides CD19?

		Thanks, Paula


Paula Imus
Flow Cytometry
LP, NCI, NIH
10 Center Drive MSC-1500
Bethesda, Md. 20892-1500



This archive was generated by hypermail 2b29 : Sun Jan 05 2003 - 19:26:11 EST